T
Tetanus, Reduced Diphtheria and Acellular Pertussis & Inactivated Poliovirus (Tdap-IPV) Vaccine
Availability of ACE Drug Guidance
No
Biologics Drug Information Overview
Yes
Subsidy Information and Financing Scheme
Subsidised Vaccine List
Active ingredients: Vaccine Tetanus | Tetanus Vaccine | Vaccine Diphtheria | Diphtheria Vaccine | Vaccine Pertussis | Pertussis Vaccine | Vaccine Poliovirus | Poliovirus Vaccine | Tetanus, Reduced Diphtheria and Acellular Pertussis & Inactivated Poliovirus (Tdap-IPV) Vaccine
General information
Subsidy Information and Financing Scheme
[SVL] Tetanus, Reduced Diphtheria and Acellular Pertussis & Inactivated Poliovirus (Tdap-IPV) (Adacel-Polio) Injection, Diphtheria Toxoid Vaccine minimum 2 international units/0.5 mL + Tetanus Toxoid Vaccine minimum 20 international units/0.5 mL + Pertussis Toxoid Vaccine 2.5 micrograms/0.5 mL + Filamentous Haemagglutinin 5 micrograms/0.5 mL + Pertactin 3 micrograms/0.5 mL + Fimbriae Type-2 & Type-3 5 micrograms/0.5 mL + Poliovirus Vaccine (inactivated) Type-1 40 D-antigen unit/0.5 mL + Poliovirus Vaccine (inactivated) Type-2 8 D-antigen unit/0.5 mL + Poliovirus Vaccine (inactivated) Type-3 32 D-antigen unit/0.5 mL
National Childhood Immunisation Schedule (NCIS)
[SVL] Tetanus, Reduced Diphtheria and Acellular Pertussis & Inactivated Poliovirus (Tdap-IPV) (Boostrix Polio) Injection, Diphtheria Toxoid Vaccine minimum 2 international units/0.5 mL + Tetanus Toxoid Vaccine minimum 20 international units/0.5 mL + Pertussis Toxoid Vaccine 8 micrograms/0.5 mL + Filamentous Haemagglutinin 8 micrograms/0.5 mL + Pertactin 2.5 micrograms/0.5 mL + Poliovirus Vaccine (inactivated) Type-1 40 D-antigen unit/0.5 mL + Poliovirus Vaccine (inactivated) Type-2 8 D-antigen unit/0.5 mL + Poliovirus Vaccine (inactivated) Type-3 32 D-antigen unit/0.5 mL
National Childhood Immunisation Schedule (NCIS)
Drug Guidance for Subsidy
Not Applicable
General Availability in Public Healthcare Institution
Note:
General availability information reflected is based on the Public Healthcare Institutions’ (PHI) formulary on what is commonly used for treating their patient population and may or may not be available for patients not under the care of that institution. It does not reflect the PHI’s actual inventory availability and is subjected to change. Please consult the Public Hospitals or Polyclinics for details on availability and supply restrictions/considerations. General availability is not tied to any brand unless otherwise stated.
Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration
Availability information
Formulation | Public Healthcare Institution |
|---|---|
Adacel-Polio Injection, Diphtheria Toxoid Vaccine minimum 2 international units/0.5 mL + Tetanus Toxoid Vaccine minimum 20 international units/0.5 mL + Pertussis Toxoid Vaccine 2.5 micrograms/0.5 mL + Filamentous Haemagglutinin 5 micrograms/0.5 mL + Pertactin 3 micrograms/0.5 mL + Fimbriae Type-2 & Type-3 5 micrograms/0.5 mL + Poliovirus Vaccine (inactivated) Type-1 40 D-antigen unit/0.5 mL + Poliovirus Vaccine (inactivated) Type-2 8 D-antigen unit/0.5 mL + Poliovirus Vaccine (inactivated) Type-3 32 D-antigen unit/0.5 mL |
|